Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA

Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF- -Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression

(2014) S. Xiao et al.   JOURNAL OF IMMUNOLOGY

New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available

(2011) V. Abramson et al.   CLINICAL CANCER RESEARCH

Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells

(2010) Valentina Colombo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Lapatinib and breast cancer: current indications and outlook for the future

(2010) Cynthia Moreira et al.   Expert Review of Anticancer Therapy

Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells

(2010) Mineko Terao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation)

(2009) Martin J Aryee et al.   BMC BIOINFORMATICS

Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells

(2009) Fu-Ming Tsai et al.   BMC CELL BIOLOGY

Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing

(2009) M. Guha et al.   CANCER RESEARCH

Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR  and PML-RAR 

(2009) M. Gianni' et al.   CANCER RESEARCH

A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer

(2009) J.-Y. Yang et al.   CLINICAL CANCER RESEARCH

The rationale and potential of cancer chemoprevention with special emphasis on breast cancer

(2009) Matteo Puntoni et al.   EUROPEAN JOURNAL OF CANCER

Molecular predictors of response to trastuzumab and lapatinib in breast cancer

(2009) Francisco J. Esteva et al.   Nature Reviews Clinical Oncology

Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity

(2009) Paola M. Barral et al.   PHARMACOLOGY & THERAPEUTICS

Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?

(2008) Antoinette R. Tan et al.   BREAST CANCER RESEARCH AND TREATMENT

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

(2008) Li Yang et al.   CANCER CELL

Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells

(2008) Chien-Chih Ou et al.   CARCINOGENESIS

Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression

(2008) J Yang et al.   ONCOGENE

Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer

(2008) Gabriella Mariani et al.   Nature clinical practice. Oncology